| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
152,273,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
8,789,578 |
Avg
Vol: |
4,077,388 |
| 52
Week Range: |
$16.96 - $16.96 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Emanuele Robert Martin |
V P, Business Development |
• – – |
2006-05-25 |
4 |
B |
$8.99 |
$8,990 |
D/D |
1,000 |
1,000 |
2.74 |
- |
|
| Brandt Eric |
President, CEO & Director |
• • – |
2006-05-25 |
4 |
B |
$8.96 |
$98,892 |
D/D |
11,000 |
261,000 |
2.81 |
- |
|
| Kaye Randall |
Chief Medical Officer |
• – – |
2006-05-08 |
4 |
OE |
$0.04 |
$500 |
I/I |
12,500 |
424,595 |
|
- |
|
| Puntoriero Michael J |
Senior VP, FinanceOfficer |
• – – |
2006-05-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
625 |
|
- |
|
| Berg James E |
VP, Clinical & Reg. Affairs |
• – – |
2006-03-01 |
4 |
OE |
$5.88 |
$22,188 |
D/D |
3,250 |
15,500 |
|
- |
|
| Sircar Jagadish C |
VP of Drug Discovery |
• – – |
2006-02-17 |
4 |
S |
$16.82 |
$60,552 |
D/D |
(3,600) |
12,625 |
|
- |
|
| Sircar Jagadish C |
VP of Drug Discovery |
• – – |
2006-02-17 |
4 |
OE |
$12.00 |
$60,000 |
D/D |
5,000 |
16,225 |
|
- |
|
| Mazzo David J |
Director |
– • – |
2006-02-14 |
4 |
B |
$15.59 |
$15,590 |
D/D |
1,000 |
7,435 |
2.39 |
- |
|
| Orbimed Capital Ii Llc |
Director |
– • – |
2006-02-13 |
4 |
A |
$0.00 |
$0 |
I/I |
2,341,693 |
2,335,258 |
|
- |
|
| Silverstein Jonathan |
Director |
– • – |
2006-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
6,435 |
6,435 |
|
- |
|
| Austin Stephen G |
Director |
– • – |
2006-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
6,435 |
8,935 |
|
- |
|
| Mathews Charles |
Director |
– • – |
2006-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
6,435 |
8,935 |
|
- |
|
| Whitcup Scott M |
Director |
– • – |
2006-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
6,435 |
6,435 |
|
- |
|
| Wheeler Craig A |
Director |
– • – |
2006-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
6,435 |
6,435 |
|
- |
|
| Mazzo David J |
Director |
– • – |
2006-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
6,435 |
6,435 |
|
- |
|
| Podlesak Dennis |
Director |
– • – |
2006-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
6,435 |
6,435 |
|
- |
|
| Thomas Paul |
Director |
– • – |
2006-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
6,435 |
6,435 |
|
- |
|
| Kaye Randall |
officerTitle |
• – – |
2006-01-16 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,250 |
|
- |
|
| Silverstein Jonathan |
Director |
– • – |
2005-10-20 |
4 |
B |
$2.65 |
$1,500,001 |
I/I |
566,038 |
9,341,038 |
2.1 |
- |
|
| Brandt Eric |
President, Chief ExecutiveOffi |
• • – |
2005-09-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,000,000 |
|
- |
|
| Silverstein Jonathan |
Director |
– • – |
2005-04-08 |
4 |
B |
$2.20 |
$1,980,000 |
I/I |
900,000 |
8,775,000 |
2.1 |
- |
|
| Yakatan Gerald J Phd |
President, Chief Executive |
• • – |
2005-03-08 |
4 |
A |
$2.65 |
$5,300,000 |
I/I |
2,000,000 |
2,000,000 |
|
- |
|
| Hansen John David |
V.P. of Corporate Development |
• – – |
2005-01-03 |
4 |
AS |
$3.39 |
$102,030 |
I/I |
(30,000) |
15,000 |
|
- |
|
| Silverstein Jonathan |
Director |
– • – |
2004-09-14 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
7,875,000 |
|
- |
|
| Hansen John David |
V.P. of Corporate Development |
• – – |
2004-09-13 |
4 |
AS |
$3.15 |
$94,518 |
I/I |
(30,000) |
30,000 |
|
- |
|
276 Records found
|
|
Page 11 of 12 |
|
|
